COMMUNIQUÉS West-GlobeNewswire

Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership
16/04/2026
Company targets one of the largest and most complex water safety markets in the U.S. to accelerate growth. SOUTH ORANGE, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology [...]
Baylor Genetics to Showcase the Impact of Early Genome Sequencing at Annual PLUGS Summit
16/04/2026
HOUSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics , a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it will be [...]
Evaxion concludes Annual General Meeting
16/04/2026
COPENHAGEN, Denmark, April 16, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, held its Annual General Meeting today [...]
MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer
16/04/2026
Exceptional measures of efficacy observed in THIO-101 Phase 2 trial to date include disease control, response rates, and survival data well above standard of care benchmarks 50,000 advanced NSCLC diagnoses in the U.S. [...]
Virbac: forte croissance de +7,7 % au premier trimestre 2026 à pcc, portée par la croissance à deux chiffres de nos plateformes prioritaires Supercharge⁴
16/04/2026
Le chiffre d'affaires du premier trimestre 2026 a atteint 384 M€ : +7,7 % à taux de change et périmètre constants par rapport au T1 2025. +2,2 % à taux réels, impactés par des effets de change significativement [...]
Purisaki Berberine Patches 2026 | Effective Weight Loss For Women Lose 12+ lbs per Month Read Benefits, Ingredients, Side Effects, Lunch in USA.
16/04/2026
Purisaki Patches For Weight loss | Read Berberine weight loss consumer reports, Benefits, Side Effects, Price & Purisaki Berberine patches where to buy? New York City, April 16, 2026 (GLOBE NEWSWIRE) -- Introducing [...]
ENvue Issues Stockholder Letter & Provides Corporate Update
16/04/2026
TYLER, Texas, April 16, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive [...]
Mapi Pharma to Present Efficacy (EDSS) Data from Glatiramer Acetate Depot Long-Acting Injection Studies in Relapsing Forms of Multiple Sclerosis (RMS) and Primary Progressive Multiple Sclerosis (PPMS) at AAN 2026
16/04/2026
Poster scheduled for presentation on Tuesday, April 21, 8:00 AM - 9:00 AM CDT NESS ZIONA, Israel, April 16, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development [...]
NBPure Launches at Target, Marking Major Retail Expansion
16/04/2026
PHOENIX, April 16, 2026 (GLOBE NEWSWIRE) -- NBPure, a trusted leader in gut-first wellness for more than 28 years, today announced its expansion into Target, a significant milestone in the brand’s continued growth and [...]
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
16/04/2026
TORONTO, Ontario and HAIFA, Israel, April 16, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (" NurExone " or the " Company "), a biopharmaceutical company developing exosome-based [...]
Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan
16/04/2026
First-of-its-kind plan expands access to comprehensive, outcomes-based family building and women’s health care with predictable costs for small U.S. employers NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. ( [...]
Omada Health to Announce First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
16/04/2026
SAN FRANCISCO, April 16, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its first quarter 2026 results on Thursday, May 7, 2026 [...]
Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026
16/04/2026
SALT LAKE CITY, April 16, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced that it will share six abstracts, including two podium [...]
Virbac: strong Q1 2026 growth of +7.7% at CERS, driven by double-digit growth of our priority Supercharge4 platforms
16/04/2026
First-quarter 2026 revenue reached €384m : +7.7% at constant exchange rate and scope (CERS) vs Q1 2025 +2.2% at actual rates impacted by significant currency headwinds Balanced growth in both segments : companion animal [...]
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
16/04/2026
-- Partnership with AMI Technologies Positions FemaSeed ® as a First-Line Infertility Treatment in Israel, Expanding Market Access to Innovative Fertility Solutions -- ATLANTA, April 16, 2026 (GLOBE NEWSWIRE) -- Femasys [...]
Confidential Care to Provide BraveMind Virtual Reality Treatment to Veterans
16/04/2026
STAMFORD, Conn., April 16, 2026 (GLOBE NEWSWIRE) -- Confidential Care in Wasilla, Alaska, is the country’s latest medical facility to partner with the national nonprofit SoldierStrong to provide a groundbreaking virtual [...]
Diverge Health adds Oakland Southfield Physicians in Michigan to List of Physician Organization Partners
16/04/2026
SOUTHFIELD, Mich., April 16, 2026 (GLOBE NEWSWIRE) -- Diverge Health, a value-based care enabler for Medicaid, today announced a partnership with Oakland Southfield Physicians (OSP), a leading Southeast Michigan [...]
Elicio Therapeutics Reports Inducement Grants
16/04/2026
BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of [...]
Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors
16/04/2026
BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large [...]

Pages